AIRNA
AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals suffering from both rare and common ailments.
AIRNA
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.airna.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
90 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving SSL By Default Google Tag Manager Apple Mobile Web Clips Icon HSTS Google Analytics WordPress
Similar Organizations
Bright Minds Biosciences
Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series A - AIRNA
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - AIRNA
+ND Capital
+ND Capital investment in Series A - AIRNA
Forbion Capital Partners
Forbion Capital Partners investment in Series A - AIRNA
Ono Venture Investment
Ono Venture Investment investment in Series A - AIRNA
+ND Capital
+ND Capital investment in Series A - AIRNA
Novalis
Novalis investment in Series A - AIRNA
ARCH Venture Partners
ARCH Venture Partners investment in Series A - AIRNA
Codon Capital
Codon Capital investment in Series A - AIRNA
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series A - AIRNA
Official Site Inspections
http://www.airna.com Semrush global rank: 1.29 M Semrush visits lastest month: 20.57 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AIRNA"
AIRNA - Crunchbase Company Profile & Funding
AIRNA focuses on RNA editing technologies to develop innovative medicines aimed at treating various diseases. The company engages in research and …See details»
Org Chart Airna - The Official Board
The org chart of Airna contains its 22 main executives including Kris Elverum, Matthew Hawryluk and Patrick Foster.See details»
AIRNA - LinkedIn
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. AIRNA’s experienced team is aiming to advance a pipeline of RNA ...See details»
Our Team — Airna
At AIRNA, we are developing potent RNA editing therapeutics to offer more hope to patients who currently have limited options. The passion, dedication, and wealth of knowledge of our team, …See details»
Vice President, People - airna.com
Specific responsibilities include: Strategy In collaboration with the CEO and leadership team, evaluate, plan, develop, and implement AIRNA’s human capital strategy to support achieving …See details»
AIRNA 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for AIRNA. Use the PitchBook Platform to explore the full profile.See details»
AIRNA - 2025 Company Profile, Funding & Competitors - Tracxn
6 days ago AIRNA is a series B company based in Cambridge (United States), founded in 2021 by Thorsten Stafforst, Paul Vogel, Tobias Merkle and Jin Billy Li. It operates as a Developer of …See details»
Airna Corporation Company Profile | Cambridge, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Airna Corporation of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
AIRNA Company Profile - Office Locations, Competitors, Revenue …
AIRNA has 5 employees across 2 locations and $30 m in total funding,. See insights on AIRNA including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
AIRNA - Funding, Financials, Valuation & Investors - Crunchbase
Sep 19, 2023 AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.See details»
Airna - VentureRadar
AIRNA is on a mission to transform the lives of patients with rare and common diseases by pioneering the discovery and development of RNA editing therapeutics. AIRNA’s powerful and …See details»
AIRNA - Products, Competitors, Financials, Employees, …
AIRNA is a biotech company focused on the discovery and development of RNA editing therapeutics within the healthcare sector. The company offers treatments aimed at restoring …See details»
Company: AIRNA - crisprmedicinenews.com
AIRNA is pioneering the discovery and development of RNA-editing therapeutics for patients with rare and common diseases. The company's founders, Thorsten Stafforst (University of …See details»
AIRNA: Harnessing the Body’s RNA-Editing System for Therapeutic ...
Feb 24, 2025 AIRNA: Harnessing the Body’s RNA-Editing System for Therapeutic Applications Boston- and Germany-based biotech startup AIRNA is pioneering a new approach to genetic …See details»
AIRNA - zoonop.com
AIRNA is a biotechnology company focused on developing RNA editing therapies targeting both rare and common diseases. Founded in 2021, AIRNA is based in Cambridge, Massachusetts, …See details»
In the News - AIRNA
Apr 1, 2025 AIRNA Appoints Matthew Hawryluk as Chief Business Officer Cambridge, MA, USA and Tübingen, Germany, January 30, 2025 – AIRNA, a biotech company pioneering RNA …See details»
AIRNA - Forbion
AIRNA is on a mission to transform the lives of patients with rare and common diseases by pioneering the discovery and development of RNA editing therapeutics. AIRNA’s powerful and …See details»
AIRNA raises $90 million to make RNA-editing drugs
Jul 31, 2024 Pharmaceutical start-up AIRNA has raised $90 million in an oversubscribed series A financing round. The firm aims to produce drugs that edit RNA transcripts in the body.See details»
More documents for AIRNA (Group) - Life-Sciences-Europe.com
AIRNA is advancing its first therapeutic program, a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well as a pipeline of …See details»
RNA editing biotech Airna adds $155M in funding
Apr 1, 2025 RNA editing biotech Airna adds $155M in funding Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease …See details»